Economic Activity and Increased Uncertainty Caused by COVID-19
First written in FY2020-Q3. 5 of 15 entries say "Mitigated", first in FY2022-Q2. Latest entry: FY2024.
Soiken Holdings moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
51 other companies' latest entry also says "Mitigated".
- FY2024MitigatedAnnual report
「During the current consolidated fiscal year, restrictions on activity related to COVID-19 were eased and economic activity was gradually normalizing, but」
The easing of activity restrictions related to COVID-19 and the normalization of economic activity continued to be disclosed, and the risk of restrictions on economic activity caused by the disease weakened. However, new sources of uncertainty, including foreign-exchange fluctuations and soaring resource prices, remained. - FY2024-Q2MitigatedAnnual report
「During the first half of the current consolidated fiscal year, the transition of COVID-19 to Category 5 under Japan’s Infectious Diseases Control Law put economic activity on a path toward normalization and the economy showed signs of a gradual recovery. However, the outlook remained uncertain due to soaring raw material and energy prices and rising prices, among other factors.」
The transition of COVID-19 to Category 5 was identified as supporting the normalization of economic activity, reducing the restrictions on economic activity caused by the disease. However, uncertainty due to soaring raw material and energy prices and rising prices continued. - FY2024-Q1MitigatedAnnual report
「During the first quarter of the current consolidated fiscal year, the transition of COVID-19 to Category 5 under Japan’s Infectious Diseases Control Law put economic activity on a path toward normalization and the economy showed signs of a gradual recovery. However, the outlook remained uncertain due to soaring raw material and energy prices and rising prices, among other factors.」
The transition of COVID-19 to Category 5 was identified as supporting the normalization of economic activity, reducing the restrictions on economic activity caused by the disease. However, uncertainty due to soaring raw material and energy prices and rising prices continued. - FY2023Spread of infection showing signs of easing, but risk of renewed expansion persistsAnnual report
「As the spread of COVID-19 began to subside, an economic recovery was expected. At present, it has not had a significant impact on the group’s performance or business operations, but if infections expand again, the group’s performance may be affected for various reasons.」
While stating that the current impact of COVID-19 is not significant, the company continues to disclose the risk of an impact on performance if infections expand again. - FY2023-Q3Easing of activity restrictions coexists with monetary tightening and higher costsAnnual report
「During the first 3 quarters of the current consolidated fiscal year, restrictions on activity related to COVID-19 were eased and economic activity was gradually normalizing. However, the outlook for the economy remained uncertain due to sharp foreign-exchange fluctuations associated with global monetary tightening and soaring resource and energy prices, among other factors.」
The company described the easing of activity restrictions related to COVID-19 and the normalization of economic activity, while uncertainty about the outlook continued due to sharp foreign-exchange fluctuations associated with global monetary tightening and soaring resource and energy prices. - FY2023-Q2Easing of activity restrictions coexists with cost and foreign-exchange risksAnnual report
「During the first half of the current consolidated fiscal year, restrictions on activity related to COVID-19 were eased and economic activity was gradually normalizing. However, the outlook for the economy remained uncertain due to sharp foreign-exchange fluctuations and soaring resource and energy prices, among other factors.」
The company described the easing of activity restrictions related to COVID-19 and the normalization of economic activity, while uncertainty about the outlook continued due to sharp foreign-exchange fluctuations and soaring resource and energy prices. - FY2023-Q1MitigatedAnnual report
「During the first quarter of the current consolidated fiscal year, restrictions on activity related to COVID-19 were eased and the economy showed signs of recovery. However, the outlook remained uncertain due to rising raw material prices and the rapid depreciation of the yen, among other factors.」
The easing of activity restrictions and the economic recovery partially reduced the restrictions on economic activity caused by COVID-19. However, uncertainty about the outlook remained due to rising raw material prices and the rapid depreciation of the yen. - FY2022-Q3WorsenedAnnual report
「During the first 3 quarters of the current consolidated fiscal year, Japan’s economy generally remained sluggish. Consumption and corporate activity were significantly constrained by the fifth and sixth waves of COVID-19, while personal consumption also struggled to grow due to rising prices associated with soaring resource prices and other factors, as well as the slowing recovery in employment and income conditions.」
In addition to the fifth and sixth waves of COVID-19, the company identified soaring resource prices, rising prices and the slowing recovery in employment and income conditions, indicating that uncertainty and adverse effects in the external economic environment had broadened from the previous quarter. - FY2022-Q2MitigatedAnnual report
「The impact of the spread of COVID-19 on the group’s performance is currently limited.」
Although the fifth wave restricted consumption and corporate activity, the company described a recovery in personal consumption and signs of an economic recovery following the lifting of the state of emergency declaration, and stated that the impact on the group’s performance was currently limited. - FY2022-Q1WorsenedAnnual report
「During the first quarter of the current consolidated fiscal year, Japan’s economy generally remained sluggish, as consumption and corporate activity were significantly constrained by the spread of the fifth wave of COVID-19, among other factors.」
The fifth wave of COVID-19 significantly constrained consumption and corporate activity, and uncertainty in the external environment continued. The company also described a trend toward lower orders in its bioevaluation systems business due to the postponement or cancellation of new projects. - FY2021-Q3WorsenedAnnual report
「During the first 3 quarters of the current consolidated fiscal year, Japan’s economy continued to recover from the sharp downturn caused by the spread of COVID-19 in the spring of the previous year, partly due to the effects of the government’s economic measures. However, economic activity was severely adversely affected by the reissuance of a state of emergency declaration in response to the rapid increase in new cases, further increasing uncertainty about the outlook.」
Although the economy was recovering, the rapid increase in new cases and the reissuance of a state of emergency declaration increased the adverse impact on economic activity and uncertainty about the outlook. - FY2021-Q2WorsenedAnnual report
「During the first half of the current consolidated fiscal year, Japan’s economy continued to recover from the sharp downturn caused by the spread of COVID-19 in the spring of the previous year, partly due to the effects of the government’s economic measures. More recently, however, the marked increase in new cases has heightened uncertainty about the outlook.」
Although the economy was recovering, the marked increase in new cases heightened uncertainty about the outlook due to COVID-19 compared with the previous disclosure. - FY2021-Q1MaterialisedAnnual report
「During the first quarter of the fiscal year under review, the spread of COVID-19 delayed the schedules for regular health checkups, specific health checkups and specific health guidance. As a result, among other factors, revenue recognised from fees for these commissioned services decreased from the same period of the previous year, and revenue from this business was ¥84 million, down 19.1% year on year.」
The impact of COVID-19 has continued to materialize in the form of delays in schedules for health examinations and specified health guidance, as well as lower revenue from the healthcare support business. - FY2020MaterialisedAnnual report
「At present, the spread of COVID-19 has not had a significant impact on the performance or business operations of the group. However, if the situation deteriorates further, the group’s performance may be adversely affected for various reasons.」
The company described specific impacts and concerns across multiple businesses, including lower cosmetics sales, delays in business meetings and visits for clinical research, and postponements of schedules for health examinations and other services. Meanwhile, it stated that the impact on full-year results would be limited. - FY2020-Q3MaterialisedAnnual report
「More recently, economic activity declined due to the spread of COVID-19 in Japan and overseas, increasing uncertainty about the outlook.」
For the first time in this quarterly report, the decline in economic activity and uncertainty about the outlook due to COVID-19 were explicitly identified as external factors. Although the formal “Business and Other Risks” section states that there were no significant changes, the analysis of operating results describes the actual impact.